Brave Asset Management Inc Editas Medicine, Inc. Transaction History
Brave Asset Management Inc
- $368 Million
- Q2 2025
A detailed history of Brave Asset Management Inc transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Brave Asset Management Inc holds 25,000 shares of EDIT stock, worth $98,000. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,000
Previous 35,000
28.57%
Holding current value
$98,000
Previous $43,000
27.91%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding EDIT
# of Institutions
218Shares Held
45.5MCall Options Held
476KPut Options Held
338K-
Black Rock Inc. New York, NY7.78MShares$30.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$28.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$7.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.88MShares$7.36 Million0.0% of portfolio
-
State Street Corp Boston, MA1.85MShares$7.24 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $269M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...